Brief: Better Therapeutics Completes Enrollment Of Pivotal Trial For BT-001
18/11/2021 13:26
Nov 18 (Reuters) - Better Therapeutics Inc BTTX.O :
* BETTER THERAPEUTICS COMPLETES ENROLLMENT OF PIVOTAL TRIAL
FOR
BT-001, A PRESCRIPTION DIGITAL THERAPEUTIC FOR TYPE 2 DIABETES
* BETTER THERAPEUTICS INC - PRIMARY ENDPOINT DATA EXPECTED
IN Q1
2022
Source text for Eikon: ID:nBw1mFl2Za
Further company coverage: BTTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Better Therapeutics
See all newsU.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
U.S. STOCKS ON THE MOVE-G-III Apparel Group, Tesla, MicroStrategy